Piga A, Galanello R, Forni G, Cappellini M, Origa R, Zappu A, Donato G, Bordone E, Lavagetto A, Zanaboni L, Sechaud R, Hewson N, Ford J, Opitz H, Alberti D. Randomized phase II trial of deferasirox (Exjade, ICL670), a once-daily, orally-administered iron chelator, in comparison to deferoxamine in thalassemia patients with transfusional iron overload. Haematologica [Internet]. 2006Jul.1 [cited 2026Nov.13];91(7):873-80. Available from: https://haematologica.org/article/view/4060